Gleissner B, Thiel E
Medical Clinic III, University Hosspital Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany.
Expert Rev Mol Diagn. 2001 Jul;1(2):191-200. doi: 10.1586/14737159.1.2.191.
B-cell precursors undergo a unique somatic immunoglobulin heavy chain gene rearrangement process. The generated VHDHJH junction is a successful marker in lymphoproliferative malignancies at initial diagnosis for detection of clonality and during treatment for monitoring minimal residual disease. VHDHJH errors are often involved in recurring structural chromosomal aberrations of lymphoid malignancies, with consequent deregulated expression of the juxtaposed oncogenes, e.g., c-myc, bcl-2 or CCND1. Besides cytogenetics, a variety of molecular techniques are becoming increasingly established, including Southern blotting, PCR and real-time PCR, as well as fluorescence in situ hybridisation. Different approaches may be chosen to evaluate lymphoid malignancies either at diagnosis or follow-up in the light of increasing relevance and proven clinical utility.
B细胞前体经历独特的体细胞免疫球蛋白重链基因重排过程。产生的VHDHJH连接是淋巴增殖性恶性肿瘤初诊时检测克隆性以及治疗期间监测微小残留病的成功标志物。VHDHJH错误常与淋巴恶性肿瘤反复出现的染色体结构畸变有关,从而导致并列的癌基因(如c-myc、bcl-2或CCND1)表达失调。除细胞遗传学外,多种分子技术也越来越成熟,包括Southern印迹法、聚合酶链反应(PCR)和实时PCR,以及荧光原位杂交。鉴于其相关性不断增加和已证实的临床实用性,在诊断或随访时可选择不同方法来评估淋巴恶性肿瘤。